Literature DB >> 9858293

Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.

A K Gupta1, P Meyer, M D Gross, L M Fig, B Shapiro.   

Abstract

Tissue deposits of amyloid may lead to various clinical symptoms and signs, depending on the site of deposition. In addition, a specific subtype of amyloidosis, AL protein type, is associated with multiple myeloma. Two cases representing contrasting examples of altered radiopharmaceutical biodistribution in myeloma and amyloidosis are presented and discussed, with a bone tracer depicting the heart and a heart tracer depicting the bones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858293     DOI: 10.1097/00003072-199812000-00006

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma.

Authors:  Tomoaki Sasaki; Atsutaka Okizaki; Koji Takahashi; Masayuki Mineta; Kenichi Nagasawa; Yasuomi Fujimoto; Kyuhei Kohda; Tamio Aburano
Journal:  Jpn J Radiol       Date:  2011-09-17       Impact factor: 2.374

2.  Diffuse Myocardial Uptake of (99m)Tc-HDP in Multiple Myeloma.

Authors:  Koray Demirel; Murat Sadic; Meliha Korkmaz; Aylin Comak; Hasan Ikbal Atilgan; Gökhan Koca
Journal:  Nucl Med Mol Imaging       Date:  2013-05-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.